ofloxacin has been researched along with olamufloxacin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kubota, Y; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y | 1 |
Domon, H; Miyazaki, S; Yamaguchi, K; Yoshizumi, S | 1 |
Akaki, T; Kajitani, H; Kawahara, S; Sakatani, M; Sato, K; Tomioka, H | 1 |
Arakaki, N; Higa, F; Kawakami, K; Koide, M; Saito, A; Shinzato, T; Tateyama, M | 1 |
4 other study(ies) available for ofloxacin and olamufloxacin
Article | Year |
---|---|
In vitro and in vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia; Chlamydophila psittaci; Fluoroquinolones; HeLa Cells; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Psittacosis; Quinolones | 1997 |
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 1998 |
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Topics: Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Quinolones | 1999 |
In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cell Line; Erythromycin; Fluoroquinolones; Guinea Pigs; Half-Life; Legionella; Legionnaires' Disease; Levofloxacin; Macrophages; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 2003 |